Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04252859 · ClinicalTrials.gov registry record · Phase 2
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
A Phase 2 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT04252859: Clinical Trial Phase 2 study, sponsored by University of Utah.
NCT04252859 is a Phase 2 study that was terminated before completion, run by University of Utah. The registered enrollment target is 44 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04252859, a Phase 2 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
FES PET/CT imaging for invasive lobular cancer
Primary Outcome
The number of known ILC sites that demonstrate abnormal FES uptake by FES-PET/CT, defined as focal uptake above background with standardized uptake value (SUV) max of 1.5 or greater, relative to the total number of known ILC sites.
Interventions
- DRUG [18F]Fluoroestradiol (FES) PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-12-11 |
| Est. Completion | 2024-12-07 |
| Phase | Phase 2 |
Why NCT04252859 stopped before completion
NCT04252859 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which [18F]Fluoroestradiol (FES) PET/CT is the first listed.
NCT04252859 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04252859 about?
NCT04252859 is a clinical study titled "[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma". FES PET/CT imaging for invasive lobular cancer
What is the current status of trial NCT04252859?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2020-12-11. Estimated completion is 2024-12-07.
What interventions are being tested in trial NCT04252859?
The interventions under investigation include: [18F]Fluoroestradiol (FES) PET/CT (DRUG).
Who is sponsoring clinical trial NCT04252859?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04252859's enrollment target sits among peer trials
44 1322nd of 2000 higher than 669 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI